The study aims to determine the role of S100P as a prognostic biomarker in distal cholangiocarcinoma (dCCA).
Conducted a proteomics study to analyze S100P levels in dCCA samples.
Evaluated the relationship between S100P levels and early recurrence/survival outcomes.
Statistical analysis utilized to establish significance and predictive capacity.
S100P levels significantly associated with early recurrence (p=0.002).
Higher S100P correlated with poorer overall survival outcomes.
Identified as a potential biomarker for postoperative risk stratification.
Abstract
= 0.002). These findings identify S100P as a prognostic biomarker for dCCA, suggesting its clinical utility for postoperative risk stratification and patient management.